Movers roundup: Jack in the Box, Oncothyreon

Movers roundup: Jack in the Box shares fall on downgrade; Oncothyreon falls on drug trial

Associated Press

Among the stock activity stories for Thursday, May 16, from AP Business News:

— Shares of Jack in the Box Inc. fell after the fast-food operator reported disappointing fiscal second-quarter revenue and was downgraded by at least one analyst.

— Shares of Oncothyreon Inc. fell after the drug developer announced new clinical trial data about an experimental lung cancer treatment that failed to improve overall survival rate.

View Comments (0)